Ohri Manu 4
4 · GT Biopharma, Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Ohri Manu
Chief Financial Officer
Transactions
- Award
Option to purchase Common Stock
2023-01-27+500,000→ 500,000 totalExercise: $0.84Exp: 2033-01-26→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.